eLife (Mar 2021)

Uncovering an allosteric mode of action for a selective inhibitor of human Bloom syndrome protein

  • Xiangrong Chen,
  • Yusuf I Ali,
  • Charlotte EL Fisher,
  • Raquel Arribas-Bosacoma,
  • Mohan B Rajasekaran,
  • Gareth Williams,
  • Sarah Walker,
  • Jessica R Booth,
  • Jessica JR Hudson,
  • S Mark Roe,
  • Laurence H Pearl,
  • Simon E Ward,
  • Frances MG Pearl,
  • Antony W Oliver

DOI
https://doi.org/10.7554/eLife.65339
Journal volume & issue
Vol. 10

Abstract

Read online

BLM (Bloom syndrome protein) is a RECQ-family helicase involved in the dissolution of complex DNA structures and repair intermediates. Synthetic lethality analysis implicates BLM as a promising target in a range of cancers with defects in the DNA damage response; however, selective small molecule inhibitors of defined mechanism are currently lacking. Here, we identify and characterise a specific inhibitor of BLM’s ATPase-coupled DNA helicase activity, by allosteric trapping of a DNA-bound translocation intermediate. Crystallographic structures of BLM-DNA-ADP-inhibitor complexes identify a hitherto unknown interdomain interface, whose opening and closing are integral to translocation of ssDNA, and which provides a highly selective pocket for drug discovery. Comparison with structures of other RECQ helicases provides a model for branch migration of Holliday junctions by BLM.

Keywords